Literature DB >> 16328759

[Early diagnosis in patients with systemic lupus erythematosus (SLE)].

M Gaubitz1, H Schotte.   

Abstract

Early diagnosis in patients with systemic lupus erythematosus (SLE) remains a challenge even to experienced rheumatologists. This is due to the diversity of presentation with single or multiple manifestations and the variable course. In contrast to the considerable progress in treatment modalities no reliable diagnostic marker has been developed in the last years. So the diagnosis is made largely on clinical grounds with great awareness of anamnestic features, thoroughly performed physical examination supported by laboratory and organspecific tests. The 1997 revised ACR classification criteria are of great value, though they do not satisfy in every single case. With respect to the potentially life or organ threatening course of SLE a good interdisciplinary cooperation of general practitioners and specialists with rheumatologists is of special importance.

Entities:  

Mesh:

Year:  2005        PMID: 16328759     DOI: 10.1007/s00393-005-0795-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  26 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?

Authors:  Piersandro Riboldi; Maria Gerosa; Gabriella Moroni; Antonella Radice; Flavio Allegri; Alberto Sinico; Angela Tincani; Pier Luigi Meroni
Journal:  Autoimmunity       Date:  2005-02       Impact factor: 2.815

3.  Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

Authors:  G S Cooper; C G Parks; E L Treadwell; E W St Clair; G S Gilkeson; P L Cohen; R A S Roubey; M A Dooley
Journal:  Lupus       Date:  2002       Impact factor: 2.911

4.  Mortality and causes of death in systemic lupus erythematosus.

Authors:  J Trager; M M Ward
Journal:  Curr Opin Rheumatol       Date:  2001-09       Impact factor: 5.006

Review 5.  Antinuclear autoantibodies in systemic lupus erythematosus.

Authors:  Amr H Sawalha; John B Harley
Journal:  Curr Opin Rheumatol       Date:  2004-09       Impact factor: 5.006

6.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

7.  Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome.

Authors:  L B Tucker; S Menon; J G Schaller; D A Isenberg
Journal:  Br J Rheumatol       Date:  1995-09

8.  "Latent lupus".

Authors:  L Ganczarczyk; M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1989-04       Impact factor: 4.666

9.  Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.

Authors:  L M Vilá; G S Alarcón; G McGwin; A W Friedman; B A Baethge; H M Bastian; B J Fessler; J D Reveille
Journal:  Rheumatology (Oxford)       Date:  2003-11-17       Impact factor: 7.580

10.  Delay in the diagnosis of SLE: the importance of arthritis/arthralgia as the initial symptom.

Authors:  Suleyman Ozbek; Murat Sert; Saime Paydas; Mehmet Soy
Journal:  Acta Med Okayama       Date:  2003-08       Impact factor: 0.892

View more
  1 in total

Review 1.  Early onset systemic lupus erythematosus: differential diagnoses, clinical presentation, and treatment options.

Authors:  Christian Michael Hedrich; Hildegard Zappel; Simon Straub; Martin W Laass; Kathrin Wieczorek; Gabriele Hahn; Georg Heubner; Manfred Gahr
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.